|
|
| 212.299 | Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial | Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial | GAUTRET, P.; LAGIER, J. C.; PAROLA, P.; HOANG, V. T.; MEDDED, L.; MAILHE, M.; DOUDIER, B.; COURJON, J.; GIORDANENGO, V.; ESTEVES VIEIRA, V.; TISSOT DUPONT, H.; HONORE, S.; COLSON, P.; CHABRIERE, E.; LA SCOLA, B.; ROLAIN, J. M.; BROUQUI, P.; RAOULT, D. | Gautret, Philippe; Lagier, Jean-Christophe; Parola, Philippe; Hoang, Van Thuan; Meddeb, Line; Mailhe, Morgane; Doudier, Barbara; Courjon, Johan; Giordanengo, Valérie; Vieira, Vera Esteves; Tissot Dupont, Hervé; Honoré, Stéphane; Colson, Philippe; ChabriÚre, Eric; La Scola, Bernard; Rolain, Jean-Marc; Brouqui, Philippe; Raoult, Didier | International Journal of Antimicrobial Agents | 10.1016/j.ijantimicag.2020.105949 | 20/03/2020 | crossref, CRESS, medRxiv |
| 175.255 | Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial | Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited | GAUTRET, P.; LAGIER, J. C.; PAROLA, P.; HOANG, V. T.; MEDDED, L.; MAILHE, M.; DOUDIER, B.; COURJON, J.; GIORDANENGO, V.; ESTEVES VIEIRA, V.; TISSOT DUPONT, H.; HONORE, S.; COLSON, P.; CHABRIERE, E.; LA SCOLA, B.; ROLAIN, J. M.; BROUQUI, P.; RAOULT, D. | Gautret, Philippe; Lagier, Jean-Christophe; Honoré, Stéphane; Hoang, Van Thuan; Colson, Philippe; Raoult, Didier | International Journal of Antimicrobial Agents | 10.1016/j.ijantimicag.2020.106243 | 04/01/2021 | CRESS |
| 155.934 | Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial | Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes | GAUTRET, P.; LAGIER, J. C.; PAROLA, P.; HOANG, V. T.; MEDDED, L.; MAILHE, M.; DOUDIER, B.; COURJON, J.; GIORDANENGO, V.; ESTEVES VIEIRA, V.; TISSOT DUPONT, H.; HONORE, S.; COLSON, P.; CHABRIERE, E.; LA SCOLA, B.; ROLAIN, J. M.; BROUQUI, P.; RAOULT, D. | Gautret, Philippe; Hoang, Van Thuan; Lagier, Jean-Christophe; Raoult, Didier | International Journal of Antimicrobial Agents | 10.1016/j.ijantimicag.2020.106239 | 04/01/2021 | CRESS |
| 143.491 | Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial | Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial. | GAUTRET, P.; LAGIER, J. C.; PAROLA, P.; HOANG, V. T.; MEDDED, L.; MAILHE, M.; DOUDIER, B.; COURJON, J.; GIORDANENGO, V.; ESTEVES VIEIRA, V.; TISSOT DUPONT, H.; HONORE, S.; COLSON, P.; CHABRIERE, E.; LA SCOLA, B.; ROLAIN, J. M.; BROUQUI, P.; RAOULT, D. | Gautret, Philippe; Hoang, Van Thuan; Lagier, Jean-Christophe; Raoult, Didier | International Journal of Antimicrobial Agents | 10.1016/j.ijantimicag.2020.106237 | 04/01/2021 | CRESS |
| 137.515 | Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial | Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19 | GAUTRET, P.; LAGIER, J. C.; PAROLA, P.; HOANG, V. T.; MEDDED, L.; MAILHE, M.; DOUDIER, B.; COURJON, J.; GIORDANENGO, V.; ESTEVES VIEIRA, V.; TISSOT DUPONT, H.; HONORE, S.; COLSON, P.; CHABRIERE, E.; LA SCOLA, B.; ROLAIN, J. M.; BROUQUI, P.; RAOULT, D. | Gautret, Philippe; Lagier, Jean-Christophe; Honoré, Stéphane; Hoang, Van Thuan; Raoult, Didier | International Journal of Antimicrobial Agents | 10.1016/j.ijantimicag.2020.106242 | 04/01/2021 | - |
| 130.499 | Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial | Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients | GAUTRET, P.; LAGIER, J. C.; PAROLA, P.; HOANG, V. T.; MEDDED, L.; MAILHE, M.; DOUDIER, B.; COURJON, J.; GIORDANENGO, V.; ESTEVES VIEIRA, V.; TISSOT DUPONT, H.; HONORE, S.; COLSON, P.; CHABRIERE, E.; LA SCOLA, B.; ROLAIN, J. M.; BROUQUI, P.; RAOULT, D. | Gautret, Philippe; Honoré, Stéphane; Lagier, Jean-Christophe; Raoult, Didier | International Journal of Antimicrobial Agents | 10.1016/j.ijantimicag.2020.106236 | 04/01/2021 | - |
| 126.985 | Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial | Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study | GAUTRET, P.; LAGIER, J. C.; PAROLA, P.; HOANG, V. T.; MEDDED, L.; MAILHE, M.; DOUDIER, B.; COURJON, J.; GIORDANENGO, V.; ESTEVES VIEIRA, V.; TISSOT DUPONT, H.; HONORE, S.; COLSON, P.; CHABRIERE, E.; LA SCOLA, B.; ROLAIN, J. M.; BROUQUI, P.; RAOULT, D. | Gautret, Philippe; Lagier, Jean-Christophe; Parola, Philippe; Hoang, Van Thuan; Meddeb, Line; Sevestre, Jacques; Mailhe, Morgane; Doudier, Barbara; Aubry, Camille; Amrane, Sophie; Seng, Piseth; Hocquart, Marie; Eldin, Carole; Finance, Julie; Vieira, Vera Esteves; Tissot-Dupont, Hervé Tissot; Honoré, Stéphane; Stein, Andreas; Million, Matthieu; Colson, Philippe; La Scola, Bernard; Veit, Véronique; Jacquier, Alexis; Deharo, Jean-Claude; Drancourt, Michel; Fournier, Pierre Edouard; Rolain, Jean-Marc; Brouqui, Philippe; Raoult, Didier | Travel Medicine and Infectious Disease | 10.1016/j.tmaid.2020.101663 | 11/04/2020 | - |
| 115.854 | Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial | Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature. | GAUTRET, P.; LAGIER, J. C.; PAROLA, P.; HOANG, V. T.; MEDDED, L.; MAILHE, M.; DOUDIER, B.; COURJON, J.; GIORDANENGO, V.; ESTEVES VIEIRA, V.; TISSOT DUPONT, H.; HONORE, S.; COLSON, P.; CHABRIERE, E.; LA SCOLA, B.; ROLAIN, J. M.; BROUQUI, P.; RAOULT, D. | Gautret, Philippe; Hoang, Van Thuan; Honoré, Stéphane; Roussel, Yanis; Million, Matthieu; Lagier, Jean-Christophe; Raoult, Didier | International Journal of Antimicrobial Agents | 10.1016/j.ijantimicag.2020.106241 | 04/01/2021 | - |
| 110.700 | Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial | Response to advances statistical methods and designs for clinical trials for COVID-19 | GAUTRET, P.; LAGIER, J. C.; PAROLA, P.; HOANG, V. T.; MEDDED, L.; MAILHE, M.; DOUDIER, B.; COURJON, J.; GIORDANENGO, V.; ESTEVES VIEIRA, V.; TISSOT DUPONT, H.; HONORE, S.; COLSON, P.; CHABRIERE, E.; LA SCOLA, B.; ROLAIN, J. M.; BROUQUI, P.; RAOULT, D. | Gautret, Philippe; Hoang, Van Thuan; Lagier, Jean-Christophe; Raoult, Didier | International Journal of Antimicrobial Agents | 10.1016/j.ijantimicag.2020.106235 | 04/01/2021 | - |
|
|
| 159.174 | The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective clinical study | The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVIDâ19 Patients: A Retrospective Cohort Study | SHI, C.; WANG, C.; WANG, H.; YANG, C.; CAI, F.; ZENG, F.; CHENG, F.; LIU, Y.; ZHOU, T.; DENG, B.; Vlodavsky, I.; LI, J.; ZHANG, Y. | Shi, Chen; Wang, Cong; Wang, Hanxiang; Yang, Chao; Cai, Fei; Zeng, Fang; Cheng, Fang; Liu, Yihui; Zhou, Taotao; Deng, Bin; Vlodavsky, Israel; Li, JinâPing; Zhang, Yu | Clinical and Translational Science | 10.1111/cts.12880 | 03/09/2020 | CRESS, medRxiv |
| 66.634 | The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective clinical study | Comprehensive Landscape of Heparin Therapy for COVID-19 | SHI, C.; WANG, C.; WANG, H.; YANG, C.; CAI, F.; ZENG, F.; CHENG, F.; LIU, Y.; ZHOU, T.; DENG, B.; Vlodavsky, I.; LI, J.; ZHANG, Y. | Shi, Chen; Tingting, Wu; Li, Jin-Ping; Sullivan, Mitchell A.; Wang, Cong; Wang, Hanxiang; Deng, Bin; Zhang, Yu | Carbohydrate Polymers | 10.1016/j.carbpol.2020.117232 | 23/10/2020 | - |
|
|
| 113.061 | Interferon-a2b treatment for COVID-19 | Interferon-α2b Treatment for COVID-19 | Zhou, Q.; Wei, X.-S.; Xiang, X.; Wang, X.; Wang, Z.-H.; Chen, V.; Shannon, C. P.; Tebbutt, S. J.; Kollmann, T. R.; Fish, E. N. | Zhou, Qiong; Chen, Virginia; Shannon, Casey P.; Wei, Xiao-Shan; Xiang, Xuan; Wang, Xu; Wang, Zi-Hao; Tebbutt, Scott J.; Kollmann, Tobias R.; Fish, Eleanor N. | Frontiers in Immunology | 10.3389/fimmu.2020.01061 | 15/05/2020 | medRxiv, crossref, CRESS |
| 111.933 | Interferon-a2b treatment for COVID-19 | Corrigendum: Interferon-α2b Treatment for COVID-19 | Zhou, Q.; Wei, X.-S.; Xiang, X.; Wang, X.; Wang, Z.-H.; Chen, V.; Shannon, C. P.; Tebbutt, S. J.; Kollmann, T. R.; Fish, E. N. | Zhou, Qiong; Chen, Virginia; Shannon, Casey P.; Wei, Xiao-Shan; Xiang, Xuan; Wang, Xu; Wang, Zi-Hao; Tebbutt, Scott J.; Kollmann, Tobias R.; Fish, Eleanor N. | Frontiers in Immunology | 10.3389/fimmu.2020.615275 | 27/10/2020 | GC |
| 76.034 | Interferon-a2b treatment for COVID-19 | Interferon-α2b Treatment for COVID-19 Is Associated with Improvements in Lung Abnormalities | Zhou, Q.; Wei, X.-S.; Xiang, X.; Wang, X.; Wang, Z.-H.; Chen, V.; Shannon, C. P.; Tebbutt, S. J.; Kollmann, T. R.; Fish, E. N. | Zhou, Qiong; MacArthur, Michael; He, Xinliang; Wei, Xiaoshan; Zarin, Payam; Hanna, Bola; Wang, Zi-Hao; Xiang, Xuan; Fish, Eleanor | Viruses | 10.3390/v13010044 | 31/12/2020 | - |
|
|
| 115.221 | Adjuvant corticosteroid therapy for critically ill patients with COVID-19 | Adjuvant corticosteroid therapy for critically ill patients with COVID-19 | Lu, X.; Chen, T.; Wang, Y.; Wang, J.; Zhang, B.; Li, Y.; Yan, F. | Lu, Xiaofan; Chen, Taige; Wang, Yang; Wang, Jun; Yan, Fangrong | Critical Care | 10.1186/s13054-020-02964-w | 19/05/2020 | medRxiv, crossref, CRESS |
| 76.863 | Adjuvant corticosteroid therapy for critically ill patients with COVID-19 | Classification of COVID-19 in intensive care patients | Lu, X.; Chen, T.; Wang, Y.; Wang, J.; Zhang, B.; Li, Y.; Yan, F. | Lu, Xiaofan; Wang, Yang; Chen, Taige; Wang, Jun; Yan, Fangrong | Critical Care | 10.1186/s13054-020-03127-7 | 09/07/2020 | - |
| 69.378 | Adjuvant corticosteroid therapy for critically ill patients with COVID-19 | Continuously available ratio of SpO2/FiO2 serves as a noninvasive prognostic marker for intensive care patients with COVID-19 | Lu, X.; Chen, T.; Wang, Y.; Wang, J.; Zhang, B.; Li, Y.; Yan, F. | Lu, Xiaofan; Jiang, Liyun; Chen, Taige; Wang, Yang; Zhang, Bing; Hong, Yizhou; Wang, Jun; Yan, Fangrong | Respiratory Research | 10.1186/s12931-020-01455-4 | 22/07/2020 | - |
|
|
| 125.097 | The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis | Clinical Factors Associated with Progression and Prolonged Viral Shedding in COVID-19 Patients: A Multicenter Study | Feng, Z.; Li, J.; Yao, S.; Yu, Q.; Zhou, W.; Mao, X.; Li, H.; Kang, W.; Ouyang, X.; Mei, J.; Zeng, Q.; Liu, J.; Ma, X.; Rong, P.; Wang, W. | Feng, Zhichao; Li, Jennifer; Yao, Shanhu; Yu, Qizhi; Zhou, Wenming; Mao, Xiaowen; Li, Huiling; Kang, Wendi; Ouyang, Xin; Mei, Ji; Zeng, Qiuhua; Liu, Jincai; Ma, Xiaoqian; Rong, Pengfei; Wang, Wei | Aging and disease | 10.14336/ad.2020.0630 | 22/09/2020 | CRESS |
| 67.184 | The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis | Association of Paraspinal Muscle Measurements on Chest Computed Tomography With Clinical Outcomes in Patients With Severe Coronavirus Disease 2019 | Feng, Z.; Li, J.; Yao, S.; Yu, Q.; Zhou, W.; Mao, X.; Li, H.; Kang, W.; Ouyang, X.; Mei, J.; Zeng, Q.; Liu, J.; Ma, X.; Rong, P.; Wang, W. | Feng, Zhichao; Zhao, Huafei; Kang, Wendi; Liu, Qin; Wu, Jianzhen; Bragazzi, Nicola Luigi; Ma, Xiaoqian; Wang, Wei; Rong, Pengfei | The Journals of Gerontology: Series A | 10.1093/gerona/glaa317 | 23/12/2020 | - |
| 62.481 | The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis | Early prediction of disease progression in COVID-19 pneumonia patients with chest CT and clinical characteristics | Feng, Z.; Li, J.; Yao, S.; Yu, Q.; Zhou, W.; Mao, X.; Li, H.; Kang, W.; Ouyang, X.; Mei, J.; Zeng, Q.; Liu, J.; Ma, X.; Rong, P.; Wang, W. | Feng, Zhichao; Yu, Qizhi; Yao, Shanhu; Luo, Lei; Zhou, Wenming; Mao, Xiaowen; Li, Jennifer; Duan, Junhong; Yan, Zhimin; Yang, Min; Tan, Hongpei; Ma, Mengtian; Li, Ting; Yi, Dali; Mi, Ze; Zhao, Huafei; Jiang, Yi; He, Zhenhu; Li, Huiling; Nie, Wei; Liu, Yin; Zhao, Jing; Luo, Muqing; Liu, Xuanhui; Rong, Pengfei; Wang, Wei | Nature Communications | 10.1038/s41467-020-18786-x | 02/10/2020 | - |
|
|
| 160.872 | An experimental trial of recombinant human interferon alpha nasal drops to prevent coronavirus disease 2019 in medical staff in an epidemic area | The Effect of Recombinant Human Interferon Alpha Nasal Drops to Prevent COVID-19 Pneumonia for Medical Staff in an Epidemic Area | Meng, Z.; Wang, T.; Li, C.; Chen, X.; Li, L.; Qin, X.; Li, H.; Luo, J. | Meng, Zhongji; Wang, Tongyu; Chen, Li; Chen, Xinhe; Li, Longti; Qin, Xueqin; Li, Hai; Luo, Jie | Current Topics in Medicinal Chemistry | 10.2174/1568026621666210429083050 | 13/05/2021 | CRESS, crossref, medRxiv |
| 108.121 | An experimental trial of recombinant human interferon alpha nasal drops to prevent coronavirus disease 2019 in medical staff in an epidemic area | The Effect of Recombinant Human Interferon Alpha Nasal Drops to Prevent COVID-19 Pneumonia for Medical Staff in an Epidemic Area | Meng, Z.; Wang, T.; Li, C.; Chen, X.; Li, L.; Qin, X.; Li, H.; Luo, J. | Meng, Zhongji | Current Topics in Medicinal Chemistry | 10.2174/18734294mte1kntec3 | 06/12/2022 | - |
| 91.940 | An experimental trial of recombinant human interferon alpha nasal drops to prevent coronavirus disease 2019 in medical staff in an epidemic area | The Effect of Recombinant Human Interferon Alpha Nasal Drops to Prevent COVID-19 Pneumonia for Medical Staff in an Epidemic Area | Meng, Z.; Wang, T.; Li, C.; Chen, X.; Li, L.; Qin, X.; Li, H.; Luo, J. | Meng, ZJ | Current Topics in Medicinal Chemistry | 10.2174/15680266mte1cntec3 | 17/07/2022 | - |
|
|
| 35.090 | BCG VACCINES MAY NOT REDUCE COVID-19 MORTALITY RATES | âTrained immunityâ from Mycobacterium spp. exposure or BCG vaccination and COVID-19 outcomes | Singh, S. | Singh, Samer; Maurya, Rajendra Prakash; Singh, Rakesh K. | PLOS Pathogens | 10.1371/journal.ppat.1008969 | 29/10/2020 | CRESS |
| 32.182 | BCG VACCINES MAY NOT REDUCE COVID-19 MORTALITY RATES | Nutritional Immunity, Zinc Sufficiency, and COVID-19 Mortality in Socially Similar European Populations | Singh, S. | Singh, Samer; Diwaker, Amita; Singh, Brijesh P.; Singh, Rakesh K. | Frontiers in Immunology | 10.3389/fimmu.2021.699389 | 17/09/2021 | - |
| 30.724 | BCG VACCINES MAY NOT REDUCE COVID-19 MORTALITY RATES | Revisiting the role of vitamin D levels in the prevention of COVID-19 infection and mortality in European countries post infections peak | Singh, S. | Singh, Samer; Kaur, Rajinder; Singh, Rakesh Kumar | Aging Clinical and Experimental Research | 10.1007/s40520-020-01619-8 | 14/08/2020 | False Positive |
| 29.462 | BCG VACCINES MAY NOT REDUCE COVID-19 MORTALITY RATES | How Strong is the Epidemiological Evidence for a Role of Vitamin D Levels on COVID-19 Infections and Mortality? | Singh, S. | Singh, Samer; Singh, Sangram; Kaur, Rajinder; Diwaker, Amita; Kishore, Dhiraj | Journal of scientific research | 10.37398/jsr.2021.650120 | 10/02/2021 | - |
|
|
| 83.426 | Shut it down: a cross country panel analysis on the efficacy of lockdown measures | The Efficacy of Lockdown Against COVID-19: A Cross-Country Panel Analysis | Alfano, V.; Ercolano, S. | Alfano, Vincenzo; Ercolano, Salvatore | Applied Health Economics and Health Policy | 10.1007/s40258-020-00596-3 | 03/06/2020 | CRESS |
| 61.974 | Shut it down: a cross country panel analysis on the efficacy of lockdown measures | Training in lockdown: The impact of stringency measures on the Tokyo 2020 Olympic Games | Alfano, V.; Ercolano, S. | Alfano, Vincenzo; Ercolano, Salvatore | International Journal of Sports Science & Coaching | 10.1177/17479541231163234 | 14/03/2023 | - |
| 53.298 | Shut it down: a cross country panel analysis on the efficacy of lockdown measures | Fear itself. Is fear a determinant of the efficacy of lockdowns? | Alfano, V.; Ercolano, S. | Alfano, Vincenzo; Ercolano, Salvatore | Socio-Economic Planning Sciences | 10.1016/j.seps.2023.101644 | 10/06/2023 | - |
| 47.532 | Shut it down: a cross country panel analysis on the efficacy of lockdown measures | The Effects of School Closures on COVID-19: A Cross-Country Panel Analysis | Alfano, V.; Ercolano, S. | Alfano, Vincenzo | Applied Health Economics and Health Policy | 10.1007/s40258-021-00702-z | 10/12/2021 | - |
|
|
| 137.680 | Impact of non-pharmaceutical interventions on documented cases of COVID-19 | Estimating the effects of non-pharmaceutical interventions on the number of new infections with COVID-19 during the first epidemic wave | Banholzer, N.; van Weenen, E.; Kratzwald, B.; Seeliger, A.; Tschernutter, D.; Bottrighi, P.; Cenedese, A.; Salles, J. P.; Vach, W.; Feuerriegel, S. | Banholzer, Nicolas; van Weenen, Eva; Lison, Adrian; Cenedese, Alberto; Seeliger, Arne; Kratzwald, Bernhard; Tschernutter, Daniel; Salles, Joan Puig; Bottrighi, Pierluigi; Lehtinen, Sonja; Feuerriegel, Stefan; Vach, Werner | PLOS ONE | 10.1371/journal.pone.0252827 | 03/06/2021 | crossref, CRESS, medRxiv |
| 91.509 | Impact of non-pharmaceutical interventions on documented cases of COVID-19 | Estimating and explaining cross-country variation in the effectiveness of non-pharmaceutical interventions during COVID-19 | Banholzer, N.; van Weenen, E.; Kratzwald, B.; Seeliger, A.; Tschernutter, D.; Bottrighi, P.; Cenedese, A.; Salles, J. P.; Vach, W.; Feuerriegel, S. | Banholzer, Nicolas; Feuerriegel, Stefan; Vach, Werner | Scientific Reports | 10.1038/s41598-022-11362-x | 09/05/2022 | - |
| 72.773 | Impact of non-pharmaceutical interventions on documented cases of COVID-19 | The methodologies to assess the effectiveness of non-pharmaceutical interventions during COVID-19: a systematic review | Banholzer, N.; van Weenen, E.; Kratzwald, B.; Seeliger, A.; Tschernutter, D.; Bottrighi, P.; Cenedese, A.; Salles, J. P.; Vach, W.; Feuerriegel, S. | Banholzer, Nicolas; Lison, Adrian; Ăzcelik, Dennis; Stadler, Tanja; Feuerriegel, Stefan; Vach, Werner | European Journal of Epidemiology | 10.1007/s10654-022-00908-y | 24/09/2022 | - |
|
|
| 131.652 | Proactive social distancing mitigates COVID-19 outbreaks within a month across 58 mainland China cities | Effects of Proactive Social Distancing on COVID-19 Outbreaks in 58 Cities, China | Du, Z.; Xu, x.; Wang, L.; Fox, S. J.; Cowling, B. J.; Galvani, A. P.; Meyers, L. A. | Du, Zhanwei; Xu, Xiaoke; Wang, Lin; Fox, Spencer J.; Cowling, Benjamin J.; Galvani, Alison P.; Meyers, Lauren Ancel | Emerging Infectious Diseases | 10.3201/eid2609.201932 | 09/06/2020 | CRESS, medRxiv |
| 69.296 | Proactive social distancing mitigates COVID-19 outbreaks within a month across 58 mainland China cities | Estimate of COVID-19 Deaths, China, December 2022âFebruary 2023 | Du, Z.; Xu, x.; Wang, L.; Fox, S. J.; Cowling, B. J.; Galvani, A. P.; Meyers, L. A. | Du, Zhanwei; Wang, Yuchen; Bai, Yuan; Wang, Lin; Cowling, Benjamin John; Meyers, Lauren Ancel | Emerging Infectious Diseases | 10.3201/eid2910.230585 | 14/09/2023 | - |
|
|
| 161.616 | Significantly Improved COVID-19 Outcomes in Countries with Higher BCG Vaccination Coverage: A Multivariable Analysis | Significantly Improved COVID-19 Outcomes in Countries with Higher BCG Vaccination Coverage: A Multivariable Analysis | Klinger, D.; Blass, I.; Rappoport, N.; Linial, M. | Klinger, Danielle; Blass, Ido; Rappoport, Nadav; Linial, Michal | Vaccines | 10.3390/vaccines8030378 | 14/07/2020 | medRxiv, CRESS, crossref |
| 52.710 | Significantly Improved COVID-19 Outcomes in Countries with Higher BCG Vaccination Coverage: A Multivariable Analysis | Bladder Cancer Immunotherapy by BCG Is Associated with a Significantly Reduced Risk of Alzheimerâs Disease and Parkinsonâs Disease | Klinger, D.; Blass, I.; Rappoport, N.; Linial, M. | Klinger, Danielle; Hill, Brian L.; Barda, Noam; Halperin, Eran; Gofrit, Ofer N.; Greenblatt, Charles L.; Rappoport, Nadav; Linial, Michal; Bercovier, HervĂ© | Vaccines | 10.3390/vaccines9050491 | 12/05/2021 | - |
|
|
| 148.011 | Extensive testing may reduce COVID-19 mortality: a lesson from northern Italy | Extensive Testing May Reduce COVID-19 Mortality: A Lesson From Northern Italy | Di Bari, M.; Balzi, D.; Carreras, G.; Onder, G. | Di Bari, Mauro; Balzi, Daniela; Carreras, Giulia; Onder, Graziano | Frontiers in Medicine | 10.3389/fmed.2020.00402 | 14/07/2020 | medRxiv, CRESS, crossref |
| 63.676 | Extensive testing may reduce COVID-19 mortality: a lesson from northern Italy | COVID-19, Vulnerability, and Long-Term Mortality in Hospitalized and Nonhospitalized Older Persons | Di Bari, M.; Balzi, D.; Carreras, G.; Onder, G. | Di Bari, Mauro; Tonarelli, Francesco; Balzi, Daniela; Giordano, Antonella; Ungar, Andrea; Baldasseroni, Samuele; Onder, Graziano; Mechi, M. Teresa; Carreras, Giulia | Journal of the American Medical Directors Association | 10.1016/j.jamda.2021.12.009 | 15/12/2021 | - |
|
|
| 105.309 | Impact of mitigating interventions and temperature on the instantaneous reproduction number in the COVID-19 epidemic among 30 US metropolitan areas | Impact of mitigating interventions and temperature on the instantaneous reproduction number in the COVID-19 pandemic among 30 US metropolitan areas | Yu, X. | Yu, Xinhua | One Health | 10.1016/j.onehlt.2020.100160 | 22/08/2020 | medRxiv, crossref, CRESS |
| 38.105 | Impact of mitigating interventions and temperature on the instantaneous reproduction number in the COVID-19 epidemic among 30 US metropolitan areas | Health service inequalities during the COVID-19 pandemic among elderly people living in large urban and non-urban areas in Florida, USA | Yu, X. | Yu, Xinhua | SAGE Open Medicine | 10.1177/2050312120974168 | 24/11/2020 | - |
|
|
| 111.137 | Hydroxychloroquine application is associated with a decreased mortality in critically ill patients with COVID-19 | Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19 | Yu, B.; Wang, D. W.; Li, C. | Yu, Bo; Li, Chenze; Chen, Peng; Zhou, Ning; Wang, Luyun; Li, Jia; Jiang, Hualiang; Wang, Dao-Wen | Science China Life Sciences | 10.1007/s11427-020-1732-2 | 16/05/2020 | CRESS |
| 110.500 | Hydroxychloroquine application is associated with a decreased mortality in critically ill patients with COVID-19 | Erratum to: Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19 | Yu, B.; Wang, D. W.; Li, C. | Yu, Bo; Li, Chenze; Chen, Peng; Zhou, Ning; Wang, Luyun; Li, Jia; Jiang, Hualiang; Wang, Dao-Wen | Science China Life Sciences | 10.1007/s11427-020-1751-3 | 22/06/2020 | GC |
| 89.084 | Hydroxychloroquine application is associated with a decreased mortality in critically ill patients with COVID-19 | Beneficial effects exerted by hydroxychloroquine in treating COVID-19 patients via protecting multiple organs | Yu, B.; Wang, D. W.; Li, C. | Yu, Bo; Li, Chenze; Chen, Peng; Li, Jia; Jiang, Hualiang; Wang, Dao-Wen | Science China Life Sciences | 10.1007/s11427-020-1782-1 | 06/08/2020 | - |
| 70.854 | Hydroxychloroquine application is associated with a decreased mortality in critically ill patients with COVID-19 | Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes | Yu, B.; Wang, D. W.; Li, C. | Yu, Bo; Li, Chenze; Sun, Yang; Wang, Dao Wen | Cell Metabolism | 10.1016/j.cmet.2020.11.014 | 23/11/2020 | - |
|
|
| 197.779 | QT Interval Prolongation and Torsade De Pointes in Patients with COVID-19 treated with Hydroxychloroquine/Azithromycin | QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin | Chorin, E.; Wadhwani, L.; Magnani, S.; Dai, M.; Shulman, E.; Nadeau-Routhier, C.; Knots, R.; Bar-Cohen, R.; Kogan, E.; Barbhaiya, C.; Aizer, A.; Holmes, D.; Bernstein, S.; Spinelli, M.; Park, D. S.; Carugo, S.; Chinitz, L. A.; Jankelosn, L. | Chorin, Ehud; Wadhwani, Lalit; Magnani, Silvia; Dai, Matthew; Shulman, Eric; Nadeau-Routhier, Charles; Knotts, Robert; Bar-Cohen, Roi; Kogan, Edward; Barbhaiya, Chirag; Aizer, Anthony; Holmes, Douglas; Bernstein, Scott; Spinelli, Michael; Park, David S.; Stefano, Carugo; Chinitz, Larry A.; Jankelson, Lior | Heart Rhythm | 10.1016/j.hrthm.2020.05.014 | 12/05/2020 | crossref, CRESS, medRxiv |
| 144.804 | QT Interval Prolongation and Torsade De Pointes in Patients with COVID-19 treated with Hydroxychloroquine/Azithromycin | Electrocardiographic Risk Stratification in COVID-19 Patients | Chorin, E.; Wadhwani, L.; Magnani, S.; Dai, M.; Shulman, E.; Nadeau-Routhier, C.; Knots, R.; Bar-Cohen, R.; Kogan, E.; Barbhaiya, C.; Aizer, A.; Holmes, D.; Bernstein, S.; Spinelli, M.; Park, D. S.; Carugo, S.; Chinitz, L. A.; Jankelosn, L. | Chorin, Ehud; Dai, Matthew; Kogan, Edward; Wadhwani, Lalit; Shulman, Eric; Nadeau-Routhier, Charles; Knotts, Robert; Bar-Cohen, Roi; Barbhaiya, Chirag; Aizer, Anthony; Holmes, Douglas; Bernstein, Scott; Spinelli, Michael; Park, David; Chinitz, Larry; Jankelson, Lior | Frontiers in Cardiovascular Medicine | 10.3389/fcvm.2021.636073 | 02/02/2021 | - |
|
|
| 93.006 | Effectiveness of the strategies implemented in Sri Lanka for controlling the COVID-19 outbreak | Effectiveness of the Strategies Implemented in Sri Lanka for Controlling the COVID-19 Outbreak | Erandi, H.; Mahasinghe, A. C.; Perera, S.; Jayasinghe, S. | Erandi, K. K. W. H.; Mahasinghe, A. C.; Perera, S. S. N.; Jayasinghe, S. | Journal of Applied Mathematics | 10.1155/2020/2954519 | 22/09/2020 | CRESS, crossref, medRxiv |
| 58.675 | Effectiveness of the strategies implemented in Sri Lanka for controlling the COVID-19 outbreak | Analysis and forecast of dengue incidence in urban Colombo, Sri Lanka | Erandi, H.; Mahasinghe, A. C.; Perera, S.; Jayasinghe, S. | Erandi, KKWH; Perera, SSN; Mahasinghe, AC | Theoretical Biology and Medical Modelling | 10.1186/s12976-020-00134-7 | 07/01/2021 | - |